David Szekeres

David Szekeres has spent more than 15 years years working in the life sciences and biotechnology industry, and is currently the chief business officer and general counsel at Heron Therapeutics. He previously served as the chief business officer and general counsel of Regulus Therapeutics and the head of mergers and acquisitions at Life Technologies Corporation (recently sold to Thermo Fisher for $16 billion). At Life Technologies, Szekeres led more than 50 transactions valued at over $30 billion, including leading the acquisition of Ion Torrent to expand the company’s genomics business. Prior to his years at Life Technologies, he held positions of increasing responsibility at a number of prestigious law firms, including Latham & Watkins LLP and O’Melveny & Myers LLP, and was an investment banking associate at Robertson Stephens. Szekeres holds a bachelor’s degree from the University of California at Irvine and a J.D. from Duke University.